- About this Journal
- Abstracting and Indexing
- Aims and Scope
- Article Processing Charges
- Articles in Press
- Author Guidelines
- Bibliographic Information
- Citations to this Journal
- Contact Information
- Editorial Board
- Editorial Workflow
- Free eTOC Alerts
- Publication Ethics
- Reviewers Acknowledgment
- Submit a Manuscript
- Subscription Information
- Table of Contents
Multiple Sclerosis International
Volume 2013 (2013), Article ID 598093, 6 pages
The Evidence for Hypoperfusion as a Factor in Multiple Sclerosis Lesion Development
1Department of Anatomy & Cell Biology, University of Saskatchewan, Saskatoon, SK, S7N 5E5, Canada
2College of Medicine, Alfaisal University, Riyadh 11533, Saudi Arabia
Received 7 November 2012; Revised 8 February 2013; Accepted 19 March 2013
Academic Editor: Bianca Weinstock-Guttman
Copyright © 2013 Bernhard H. J. Juurlink. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- B. V. Taylor, “The major cause of multiple sclerosis is environmental: genetics has a minor role—yes,” Multiple Sclerosis, vol. 17, pp. 1171–1173, 2011.
- F. Gonzalez-Andrade and J. L. Alcaraz-Alvarez, “Disease-modifying therapies in relapsing-remitting multiple sclerosis,” Neuropsychiatric Disease and Treatment, vol. 6, pp. 365–373, 2010.
- M. K. Birch, S. Barbosa, L. D. Blumhardt, C. O'Brien, and S. P. Harding, “Retinal venous sheathing and the blood-retinal barrier in multiple sclerosis,” Archives of Ophthalmology, vol. 114, no. 1, pp. 34–39, 1996.
- B. H. J. Juurlink, “The multiple sclerosis lesion: initiated by a localized hypoperfusion in a central nervous system where mechanisms allowing leukocyte infiltration are readily upregulated?” Medical Hypotheses, vol. 51, no. 4, pp. 299–303, 1998.
- G. R. Moore, “Current concepts in the neuropathology and pathogenesis of multiple sclerosis,” The Canadian Journal of Neurological Sciences, vol. 37, supplement, pp. S5–S15, 2010.
- P. Zamboni, E. Menegatti, I. Bartolomei et al., “Intracranial venous haemodynamics in multiple sclerosis,” Current Neurovascular Research, vol. 4, no. 4, pp. 252–258, 2007.
- C. Lucchinetti, W. Bruck, J. Parisi, B. Scheithauer, M. Rodriguez, and H. Lassmann, “Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination,” Annals of Neurology, vol. 47, pp. 707–717, 2000.
- M. H. Barnett and J. W. Prineas, “Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion,” Annals of Neurology, vol. 55, no. 4, pp. 458–468, 2004.
- A. P. D. Henderson, M. H. Barnett, J. D. E. Parratt, and J. W. Prineas, “Multiple sclerosis: distribution of inflammatory cells in newly forming lesions,” Annals of Neurology, vol. 66, no. 6, pp. 739–753, 2009.
- J. W. Prineas and J. D. Parratt, “Oligodendrocytes and the early multiple sclerosis lesion,” Annals of Neurology, vol. 72, pp. 18–31, 2012.
- E. C. W. Breij, B. P. Brink, R. Veerhuis et al., “Homogeneity of active demyelinating lesions in established multiple sclerosis,” Annals of Neurology, vol. 63, no. 1, pp. 16–25, 2008.
- F. Aboul-Enein, H. Rauschka, B. Kornek et al., “Preferential loss of myelin-associated glycoprotein reflects hypoxia-like white matter damage in stroke and inflammatory brain diseases,” Neuropathology and Experimental Neurology, vol. 62, no. 1, pp. 25–33, 2003.
- S. N. Greer, J. L. Metcalf, Y. Wang, and M. Ohh, “The updated biology of hypoxia-inducible factor,” EMBO Journal, vol. 31, pp. 2448–2460, 2012.
- H. Lassmann, M. Reindl, H. Rauschka et al., “A new paraclinical CSF marker for hypoxia-like tissue damage in multiple sclerosis lesions,” Brain, vol. 126, no. 6, pp. 1347–1357, 2003.
- A. N. Mháille, S. McQuaid, A. Windebank et al., “Increased expression of endoplasmic reticulum stress-related signaling pathway molecules in multiple sclerosis lesions,” Neuropathology and Experimental Neurology, vol. 67, no. 3, pp. 200–211, 2008.
- C. T. Taylor, “Interdependent roles for hypoxia inducible factor and nuclear factor-κB in hypoxic inflammation,” Journal of Physiology, vol. 586, no. 17, pp. 4055–4059, 2008.
- U. Graumann, R. Reynolds, A. J. Steck, and N. Schaeren-Wiemers, “Molecular changes in normal appearing white matter in multiple sclerosis are characteristic of neuroprotective mechanisms against hypoxic insult,” Brain Pathology, vol. 13, no. 4, pp. 554–573, 2003.
- J. E. Holley, J. Newcombe, J. L. Whatmore, and N. J. Gutowski, “Increased blood vessel density and endothelial cell proliferation in multiple sclerosis cerebral white matter,” Neuroscience Letters, vol. 470, no. 1, pp. 65–70, 2010.
- G. Bánhegyi, J. Mandl, and M. Csala, “Redox-based endoplasmic reticulum dysfunction in neurological diseases,” Journal of Neurochemistry, vol. 107, no. 1, pp. 20–34, 2008.
- P. Cunnea, A. N. Mháille, S. McQuaid, M. Farrell, J. McMahon, and U. Fitzgerald, “Expression profiles of endoplasmic reticulum stress-related molecules in demyelinating lesions and multiple sclerosis,” Multiple Sclerosis, vol. 17, no. 7, pp. 808–818, 2011.
- E. Dux, P. Temesvari, and F. Joo, “The blood-brain barrier in hypoxia: ultrastructural aspects and adenylate cyclase activity of brain capillaries,” Neuroscience, vol. 12, no. 3, pp. 951–958, 1984.
- J. F. Schmedtje Jr., Y. S. Ji, W. L. Liu, R. N. DuBois, and M. S. Runge, “Hypoxia induces cyclooxygenase-2 via the NF-κB p65 transcription factor in human vascular endothelial cells,” Journal of Biological Chemistry, vol. 272, no. 1, pp. 601–608, 1997.
- E. Farkas, G. Donka, R. A. I. de Vos, A. Mihály, F. Bari, and P. G. M. Luiten, “Experimental cerebral hypoperfusion induces white matter injury and microglial activation in the rat brain,” Acta Neuropathologica, vol. 108, no. 1, pp. 57–64, 2004.
- J. Husain and B. H. J. Juurlink, “Oligodendroglial precursor cell susceptibility to hypoxia is related to poor ability to cope with reactive oxygen species,” Brain Research, vol. 698, no. 1-2, pp. 86–94, 1995.
- S. E. Jelinski, J. Y. Yager, and B. H. J. Juurlink, “Preferential injury of oligodendroblasts by a short hypoxic-ischemic insult,” Brain Research, vol. 815, no. 1, pp. 150–153, 1999.
- M. M. Reimer, J. McQueen, L. Searcy, et al., “Rapid disruption of axon-glial integrity in response to mild cerebral hypoperfusion,” Journal of Neuroscience, vol. 31, pp. 18185–18194, 2011.
- P. K. Stys, “Axonal degeneration in multiple sclerosis: is it time for neuroprotective strategies?” Annals of Neurology, vol. 55, no. 5, pp. 601–603, 2004.
- B. D. Trapp and P. K. Stys, “Virtual hypoxia and chronic necrosis of demyelinated axons in multiple sclerosis,” The Lancet Neurology, vol. 8, no. 3, pp. 280–291, 2009.
- M. Law, A. M. Saindane, Y. Ge et al., “Microvascular abnormality in relapsing-remitting multiple sclerosis: perfusion MR imaging findings in normal-appearing white matter,” Radiology, vol. 231, no. 3, pp. 645–652, 2004.
- A. W. Varga, G. Johnson, J. S. Babb, J. Herbert, R. I. Grossman, and M. Inglese, “White matter hemodynamic abnormalities precede sub-cortical gray matter changes in multiple sclerosis,” Journal of the Neurological Sciences, vol. 282, no. 1-2, pp. 28–33, 2009.
- Y. Ge, M. Law, G. Johnson et al., “Dynamic susceptibility contrast perfusion MR imaging of multiple sclerosis lesions: characterizing hemodynamic impairment and inflammatory activity,” American Journal of Neuroradiology, vol. 26, no. 6, pp. 1539–1547, 2005.
- S. Adhya, G. Johnson, J. Herbert et al., “Pattern of hemodynamic impairment in multiple sclerosis: dynamic susceptibility contrast perfusion MR imaging at 3.0T,” NeuroImage, vol. 33, no. 4, pp. 1029–1035, 2006.
- M. Inglese, S. Adhya, G. Johnson et al., “Perfusion magnetic resonance imaging correlates of neuropsychological impairment in multiple sclerosis,” Journal of Cerebral Blood Flow and Metabolism, vol. 28, no. 1, pp. 164–171, 2008.
- C. M. Holland, A. Charil, I. Csapo et al., “The relationship between normal cerebral perfusion patterns and white matter lesion distribution in 1,249 patients with multiple sclerosis,” Journal of Neuroimaging, vol. 22, pp. 129–136, 2012.
- J. De Keyser, C. Steen, J. P. Mostert, and M. W. Koch, “Hypoperfusion of the cerebral white matter in multiple sclerosis: possible mechanisms and pathophysiological significance,” Journal of Cerebral Blood Flow and Metabolism, vol. 28, no. 10, pp. 1645–1651, 2008.
- M. D'haeseleer, M. Cambron, L. Vanopdenbosch, and J. De Keyser, “Vascular aspects of multiple sclerosis,” The Lancet Neurology, vol. 10, no. 7, pp. 657–666, 2011.
- G. R. J. Gordon, S. J. Mulligan, and B. A. MacVicar, “Astrocyte control of the cerebrovasculature,” GLIA, vol. 55, no. 12, pp. 1214–1221, 2007.
- A. M. Saindane, M. Law, Y. Ge, G. Johnson, J. S. Babb, and R. I. Grossman, “Correlation of diffusion tensor and dynamic perfusion MR imaging metrics in normal-appearing corpus callosum: support for primary hypoperfusion in multiple heterosis,” American Journal of Neuroradiology, vol. 28, no. 4, pp. 767–772, 2007.
- S. Sawcer, G. Hellenthal, M. Pirinen, et al., “Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis,” Nature, vol. 476, pp. 214–219, 2011.
- J. H. Wang, D. Pappas, P. L. De Jager et al., “Modeling the cumulative genetic risk for multiple sclerosis from genome-wide association data,” Genome Medicine, vol. 3, no. 1, article 3, 2011.
- P. Zamboni, R. Galeotti, E. Menegatti et al., “Chronic cerebrospinal venous insufficiency in patients with multiple sclerosis,” Journal of Neurology, Neurosurgery and Psychiatry, vol. 80, no. 4, pp. 392–399, 2009.
- P. Zamboni, R. Galeotti, E. Menegatti et al., “A prospective open-label study of endovascular treatment of chronic cerebrospinal venous insufficiency,” Journal of Vascular Surgery, vol. 50, no. 6, pp. 1348–1358, 2009.
- C. Baracchini, M. Atzori, and P. Gallo, “CCSVI and MS: no meaning, no fact,” Neurological Sciences, vol. 34, no. 3, pp. 269–279, 2012.
- D. Utriainen, W. Feng, S. Elias, Z. Latif, D. Hubbard, and E. M. Haacke, “Using magnetic resonance imaging as a means to study chronic cerebral spinal venous insufficiency in multiple sclerosis patients,” Techniques in Vascular and Interventional Radiology, vol. 15, pp. 101–112, 2012.
- E. M. Haacke, W. Feng, D. Utrianen, et al., “Patients with multiple sclerosis with structural venous abnormalities on MRI imaging exhibit an abnormal flow distribution of the internal jugular veins,” Journal of Vascular and Interventional Radiology, vol. 23, pp. 60–68, 2012.
- D. Hubbard, D. Ponec, J. Gooding, R. Saxon, H. Sauder, and M. Haacke, “Clinical improvement after extracranial venoplasty in multiple sclerosis,” Journal of Vascular and Interventional Radiology, vol. 23, pp. 1302–1308, 2012.
- N. Farooqi, B. Gran, and C. S. Constantinescu, “Are current disease-modifying therapeutics in multiple sclerosis justified on the basis of studies in experimental autoimmune encephalomyelitis?” Journal of Neurochemistry, vol. 115, no. 4, pp. 829–844, 2010.
- A. Shirani, Y. Zhao, M. E. Karim, et al., “Association between use of interferon beta and progression of disability in patients with relapsing-remitting multiple sclerosis,” Journal of the American Medical Association, vol. 308, pp. 247–256, 2012.
- L. La Mantia, L. Vacchi, M. Rovaris, et al., “Interferon beta for secondary progressive multiple sclerosis: a systematic review,” Journal of Neurology, Neurosurgery & Psychiatry, vol. 84, pp. 420–426, 2013.
- E. M. Haacke, “Chronic cerebral spinal venous insufficiency in multiple sclerosis,” Expert Review of Neurotherapeutics, vol. 11, no. 1, pp. 5–9, 2011.
- T. J. Putnam, “Studies in multiple sclerosis: encephalitis and sclerotic plaques produced by venular obstructions,” Archives of Neurology & Psychiatry, vol. 33, pp. 929–940, 1935.